Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Prescription Drugs: Implications of Drug Labeling and Off-Label Use

  Premium   Download PDF Now (12 pages)
Report Type Reports and Testimonies
Report Date Sept. 12, 1996
Report No. T-HEHS-96-212
Subject
Summary:

Physicians use a drug "off-label" when they prescribe a Food and Drug Administration (FDA)-approved drug for treatments other than those specified on the label. GAO testified that off-label prescribing is prevalent and presents various problems for policy-makers at different times. As it stands now, the problem is that the drug industry believes that labels overly constrain its ability to promote its products. This problem can be solved either by relying on sources in addition to the label to define appropriate promotion or by improving the process for updating the label. These two options are not necessarily mutually exclusive and both have benefits and drawbacks.

« Return to search Government Accountability Office reports